Jasper Therapeutics earnings were -$90.9M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest JSPR earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$26.7M, up 25.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, JSPR reported annual earnings of -$71.3M, with 10.6% growth.
Jasper Therapeutics Earnings Reports & History FAQ
What were Jasper Therapeutics's earnings last quarter?
Jasper Therapeutics (NASDAQ: JSPR) reported Q2 2025 earnings per share (EPS) of -$1.74, up 79.38% year over year. Total JSPR earnings for the quarter were -$26.72 million. In the same quarter last year, Jasper Therapeutics's earnings per share (EPS) was -$0.97.
Is Jasper Therapeutics profitable or losing money?
As of the last Jasper Therapeutics earnings report, Jasper Therapeutics is currently losing money. Jasper Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$90.92 million, a 45.62% increase year over year.
What was JSPR's earnings growth in the past year?
As of Jasper Therapeutics's earnings date in Q3 2025, Jasper Therapeutics's earnings has grown year over year. JSPR earnings in the past year totalled -$90.92 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.